Distribution of NNAs over each age category and the corresponding risk estimates for the presence of NNAs
| . | Patients . | . | . | . | ||||
|---|---|---|---|---|---|---|---|---|
| Age at screening (months) . | Total . | NNA-negative . | NNA-positive . | OR . | 95% CI . | P* . | ||
| No. . | % . | No. . | % . | |||||
| All | 237 | 219 | 92.4 | 18 | 7.6 | |||
| ≥40 | 25 | 20 | 80.0 | 5 | 20.0 | 6.50 | 1.43-29.52 | .018 |
| 30-39 | 23 | 20 | 87.0 | 3 | 13.0 | 3.90 | 0.73-20.80 | .101 |
| 20-29 | 41 | 38 | 92.7 | 3 | 7.3 | 2.05 | 0.40-10.65 | .319 |
| 10-19 | 67 | 63 | 94.0 | 4 | 6.0 | 1.65 | 0.36-7.65 | .331 |
| 0-9 | 81 | 78 | 96.3 | 3 | 3.7 | 1.0 | Ref | |
| . | Patients . | . | . | . | ||||
|---|---|---|---|---|---|---|---|---|
| Age at screening (months) . | Total . | NNA-negative . | NNA-positive . | OR . | 95% CI . | P* . | ||
| No. . | % . | No. . | % . | |||||
| All | 237 | 219 | 92.4 | 18 | 7.6 | |||
| ≥40 | 25 | 20 | 80.0 | 5 | 20.0 | 6.50 | 1.43-29.52 | .018 |
| 30-39 | 23 | 20 | 87.0 | 3 | 13.0 | 3.90 | 0.73-20.80 | .101 |
| 20-29 | 41 | 38 | 92.7 | 3 | 7.3 | 2.05 | 0.40-10.65 | .319 |
| 10-19 | 67 | 63 | 94.0 | 4 | 6.0 | 1.65 | 0.36-7.65 | .331 |
| 0-9 | 81 | 78 | 96.3 | 3 | 3.7 | 1.0 | Ref | |
P value is the comparison of each age category to the reference (Ref).